Cancer drug vorasidenib put to the test: will it clash with common meds?
NCT ID NCT07235748
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study in 28 healthy adults checks whether the experimental cancer drug vorasidenib changes how the body processes several common medications, including pain relievers, sedatives, and cholesterol drugs. Participants take the other drugs alone and then again with vorasidenib to compare levels in the blood. The goal is to identify potential drug interactions before vorasidenib is used more widely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
vorasidenib
What this could lead to
If successful, this study will help doctors understand how vorasidenib interacts with other medications, leading to safer dosing guidelines for patients.
What could go wrong
This is an early-phase study in healthy volunteers, not patients. The results may not fully predict effects in people with illness, and drug interactions can still vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Belfast, BT9 6AD, United Kingdom